Aatru Medical, LLC

Aatru Medical, LLC

Aatru is focused on wound and damaged skin treatment. The company is developing patent-pending controlled pressure products that, when FDA cleared,  promise improved patient care and wellbeing. Through innovative thinking, design, and reduced cost to patient and health care providers, Aatru anticipates compelling returns for investors.

 

Aatru Technology Platform

The Aatru technology platform  includes a portable, wearable completely self-contained, negative pressure bandage, which is not yet FDA-cleared and a separate product designed to treat cosmetically damaged skin. Each device may have the potential to be a market innovator with global market potential.

 

Negative Pressure Wound Therapy (NPWT)

When FDA-cleared, the Aatru bandage is expected to deliver a partial vacuum to the wound area.  NPWT is known to help draw wound edges together, increase circulation in the wound bed, reduce wound exudate, and promote granulation tissue formation (the connective tissue in healing wounds).  Wide clinical use today supports the effectiveness of NPWT.  The Aatru solution would be self-powered, completely portable and wearable.

 

Wrinkle Treatment and Tissue Treatment

Aatru anticipates a cosmetic solution that leverages the same novel technology of the wound therapy solution, with self-adhering wrinkle treatment tabs and strips that may smooth the appearance of fine lines and wrinkles on the neck and face.